Inhibition of WNK Kinases in NK Cells Disrupts Cellular Osmoregulation and Control of Tumor Metastasis

Overview

Journal J Innate Immun

Publisher Karger

Specialty Allergy & Immunology

Date 2024 Sep 12

PMID 39265537

Authors

Ji Sung Kim

John H Kehrl

Affiliations

Soon will be listed here.

Abstract

Introduction: The serine/threonine with-no-lysine (WNK) kinase family function in blood pressure control, electrolyte homeostasis, and cellular osmoregulation. These kinases and their downstream effectors are considered promising therapeutic targets in hypertension and stroke. However, the role of WNK kinases in immune cells remains poorly understood.

Methods: Using the small-molecule WNK kinase inhibitors WNK463 and WNK-IN-11, we investigated how WNK kinase inhibition affects natural killer (NK) cell physiology.

Results: WNK kinase inhibition with WNK463 or WNK-IN-11 significantly decreased IL-2-activated NK cell volume, motility, and cytolytic activity. Treatment of NK cells with these inhibitors induced autophagy by activating AMPK and inhibiting mTOR signaling. Moreover, WNK kinase inhibition increased phosphorylation of Akt and c-Myc by misaligning activity of activating kinases and inhibitory phosphatases. Treatment of tumor-bearing mice with WNK463 impaired tumor metastasis control by adoptively transferred NK cells.

Conclusion: The catalytic activity of WNK kinases has a critical role of multiple aspects of NK cell physiology and their pharmacologic inhibition negatively impacts NK cell function.

References

Plaza-Zabala A, Sierra-Torre V, Sierra A . Assessing Autophagy in Microglia: A Two-Step Model to Determine Autophagosome Formation, Degradation, and Net Turnover. Front Immunol. 2021; 11:620602. PMC: 7878397. DOI: 10.3389/fimmu.2020.620602. View

Inoue K, Furukawa T, Kumada T, Yamada J, Wang T, Inoue R . Taurine inhibits K+-Cl- cotransporter KCC2 to regulate embryonic Cl- homeostasis via with-no-lysine (WNK) protein kinase signaling pathway. J Biol Chem. 2012; 287(25):20839-50. PMC: 3375508. DOI: 10.1074/jbc.M111.319418. View

Lalioti M, Zhang J, Volkman H, Kahle K, Hoffmann K, Toka H . Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006; 38(10):1124-32. DOI: 10.1038/ng1877. View

Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K . Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol. 2004; 24(19):8778-89. PMC: 516764. DOI: 10.1128/MCB.24.19.8778-8789.2004. View

Rubinsztein D, Cuervo A, Ravikumar B, Sarkar S, Korolchuk V, Kaushik S . In search of an "autophagomometer". Autophagy. 2009; 5(5):585-9. DOI: 10.4161/auto.5.5.8823. View

Gingras A, Gygi S, Raught B, Polakiewicz R, Abraham R, Hoekstra M . Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 1999; 13(11):1422-37. PMC: 316780. DOI: 10.1101/gad.13.11.1422. View

Ho Y, Chang J, Yeh K, Gong Z, Lin Y, Lu J . Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma. In Vivo. 2020; 34(5):2631-2640. PMC: 7652442. DOI: 10.21873/invivo.12081. View

Ouwerkerk R, Bleich K, Gillen J, Pomper M, Bottomley P . Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology. 2003; 227(2):529-37. DOI: 10.1148/radiol.2272020483. View

Hann S, Eisenman R . Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol Cell Biol. 1984; 4(11):2486-97. PMC: 369080. DOI: 10.1128/mcb.4.11.2486-2497.1984. View

10.

Mori T, Kikuchi E, Watanabe Y, Fujii S, Ishigami-Yuasa M, Kagechika H . Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy. Biochem J. 2013; 455(3):339-45. DOI: 10.1042/BJ20130597. View

11.

Yoon H, Kim G, Oh S, Kim H, Kim Y, Lee Y . WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function. Exp Mol Med. 2022; 54(11):1913-1926. PMC: 9722663. DOI: 10.1038/s12276-022-00876-z. View

12.

Oshidari R, Mekhail K, Seeber A . Mobility and Repair of Damaged DNA: Random or Directed?. Trends Cell Biol. 2019; 30(2):144-156. DOI: 10.1016/j.tcb.2019.11.003. View

13.

Chi R, Wang T, Huang C, Wu S, Young S, Lydon J . WNK1 regulates uterine homeostasis and its ability to support pregnancy. JCI Insight. 2020; 5(22). PMC: 7710275. DOI: 10.1172/jci.insight.141832. View

14.

Verissimo F, Jordan P . WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene. 2001; 20(39):5562-9. DOI: 10.1038/sj.onc.1204726. View

15.

Mayes-Hopfinger L, Enache A, Xie J, Huang C, Kochl R, Tybulewicz V . Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis. Nat Commun. 2021; 12(1):4546. PMC: 8316491. DOI: 10.1038/s41467-021-24784-4. View

16.

Fujiwara T, Iwasawa K, Kalay Z, Tsunoyama T, Watanabe Y, Umemura Y . Confined diffusion of transmembrane proteins and lipids induced by the same actin meshwork lining the plasma membrane. Mol Biol Cell. 2016; 27(7):1101-19. PMC: 4814218. DOI: 10.1091/mbc.E15-04-0186. View

17.

Zhu W, Begum G, Pointer K, Clark P, Yang S, Lin S . WNK1-OSR1 kinase-mediated phospho-activation of Na+-K+-2Cl- cotransporter facilitates glioma migration. Mol Cancer. 2014; 13:31. PMC: 3936893. DOI: 10.1186/1476-4598-13-31. View

18.

Tu S, Bugde A, Luby-Phelps K, Cobb M . WNK1 is required for mitosis and abscission. Proc Natl Acad Sci U S A. 2011; 108(4):1385-90. PMC: 3029763. DOI: 10.1073/pnas.1018567108. View

19.

Hwang I, Kim J, Harrison K, Park C, Shi C, Kehrl J . Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling. Sci Signal. 2024; 17(851):eade1119. PMC: 11542683. DOI: 10.1126/scisignal.ade1119. View

20.

Zhang J, Bhuiyan M, Zhang T, Karimy J, Wu Z, Fiesler V . Modulation of brain cation-Cl cotransport via the SPAK kinase inhibitor ZT-1a. Nat Commun. 2020; 11(1):78. PMC: 6946680. DOI: 10.1038/s41467-019-13851-6. View